Leukocytes - ObeSity - Spontaneous Labour (LOST)

June 10, 2024 updated by: Centre Hospitalier Universitaire Dijon

Is Impaired Activation and Migration of Circulating Leukocytes Associated With Overdue Birth in Obese Women?

This is a single-centre observational, prospective study carried out at the maternity unit of Dijon CHU. It will include pregnant women with a pre-conception BMI ≥ 30 kg/m² and will evaluate in these patients, the activation and migration capacities of circulating leukocytes and their association with the onset of spontaneous labour.

Patients who meet the inclusion criteria will be informed about the study during their consultation at the 7th or 8th month, and their gynecologist will invite them to take part. If the answer is positive, the patients will be seen again at a specific consultation for the study between the 37th and 38the Weeks of amenorrhea at the maternity unit of Dijon CHU. During this consultation, the gynecologist will conduct a medical examination, while the Plurithematic clinical investigation center nurse will take a blood sample (3 x 6ml tubes and 1 x 7ml tube).

If labour has not started by 41 Weeks of amenorrhea, the patients will be seen at another consultation (consultation programmed in the usual follow-up of pregnancy) and a second blood sample (1 x 6ml tube and 1 x 7ml) will be taken.

The patients will be followed until childbirth and will be split into two groups according to whether or not they gave birth after the onset of spontaneous labour.

Study Overview

Study Type

Interventional

Enrollment (Actual)

88

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dijon, France, 21079
        • Chu de Dijon

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient has given its written consent
  • Please affiliated to a social security scheme
  • Body Mass Index Preconception ≥ 30 kg / m²
  • Age> 18 years
  • Unique Pregnancy
  • Having a plot of Normal Fetal heart rate

Exclusion Criteria:

  • Pathology changing the mode of delivery or induction of labor (pre-eclampsia, chronic hypertension or gestational, diabetes under unbalanced diet, ...)
  • Scheduled Caesarean
  • Infectious Disease suspected or proven, including HIV infection, hepatitis C, hepatitis B
  • Pathology inflammatory or autoimmune
  • Anti-inflammatory or immunosuppressive therapy
  • Patient under guardianship
  • Patient in safeguarding justice

    • SECONDARY EXCLUSION CRITERIA:

  • Caesarean section before labor
  • Delivery before 37 Weeks of amenorrhea
  • Anti-inflammatory or immunosuppressive therapy during study participation
  • Fetal Heart Rate abnormal during study participation
  • Premature rupture of fetal membranes without formal labor spontaneously within 48 hours
  • Induction of labor or cervical ripening before 41SA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients with pre-conceptional obesity

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
To determine the initiation of spontaneous labour
Time Frame: Women will be followed until the release of motherhood after giving birth
Women will be followed until the release of motherhood after giving birth

Secondary Outcome Measures

Outcome Measure
Time Frame
Occurrence of a vaginal delivery
Time Frame: Women will be followed until the release of motherhood after giving birth
Women will be followed until the release of motherhood after giving birth
Occurrence of prolonged pregnancy
Time Frame: Women will be followed until the release of motherhood after giving birth
Women will be followed until the release of motherhood after giving birth
Occurrence of a term exceeding
Time Frame: Women will be followed until the release of motherhood after giving birth
Women will be followed until the release of motherhood after giving birth

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 5, 2014

Primary Completion (Actual)

October 22, 2023

Study Completion (Actual)

October 22, 2023

Study Registration Dates

First Submitted

March 5, 2014

First Submitted That Met QC Criteria

March 11, 2014

First Posted (Estimated)

March 13, 2014

Study Record Updates

Last Update Posted (Actual)

June 11, 2024

Last Update Submitted That Met QC Criteria

June 10, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • WENDREMAIRE APJ 2013

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pre-conceptional Obesity

Clinical Trials on Blood samples at 37-38 Weeks of amenorrhea

Subscribe